HHS: Paxlovid to be repackaged for appropriate dosing in kidney patients … Study: Some 40% of community-dwelling seniors are inadequately hydrated … “Bivalent” booster offers better protection...
‘They heard us’: Partner program to allow fast LTC access to federal stock of COVID-19 drugs
By
Alicia Lasek
Mar 04, 2022
The federal Long-Term Care Partner Program aims to quickly get time-sensitive COVID-19 treatments to facilities when an outbreak occurs. The first drug available via the portal will be molnupiravir, followed...
Long-term care facilities to receive expedited meds under National COVID-19 Preparedness Plan
By
Alicia Lasek
Mar 03, 2022
Hundreds of facilities will be able to directly order COVID-19 antiviral drugs and receive direct distributions starting this month, federal officials say.
Clinical briefs for Thursday, Jan. 20
By
Alicia Lasek
Jan 20, 2022
Senior housing analysts report on rising SNF coronavirus cases … Paxlovid antiviral COVID-19 pill appears to be effective against omicron … Nearly half of American adults have gained weight during...
Supplies of groundbreaking COVID-19 pills Paxlovid, molnupiravir remain scarce
By
Alicia Lasek
Jan 14, 2022
U.S. clinicians may have to wait longer to receive a steady supply of highly anticipated COVID-19 antiviral pills as they manage the omicron variant surge.
Clinical briefs for Friday, Jan. 7
By
Alicia Lasek
Jan 07, 2022
Nurses’ unions ask federal court to intervene with OSHA protections for healthcare workers … Omicron may be less severe in older patients, but not “mild,” WHO reports … Feds have no plans to...
U.S. doubles order of Paxlovid antiviral pill to 20M
By
Alicia Lasek
Jan 05, 2022
The initial supply of the COVID-19 medication will be limited, and shipments to states will be spread out over time, “ramping up steadily in the months ahead,” according to the Department of Health...
FDA set to approve two COVID-19 antiviral pills this week
By
Alicia Lasek
Dec 22, 2021
FDA is expected to grant emergency use authorization to two antiviral COVID-19 pills this week, possibly as early as today, according to Bloomberg News, citing sources familiar with the matter.
Pfizer says final data show COVID-19 pill stays strong against severe illness
Dec 14, 2021
Latest results show that drug cuts hospitalizations, deaths by nearly 90 percent when taken within three to five days of the start of symptoms